CN101721378B - 盐酸头孢甲肟冻干粉针的制备方法 - Google Patents
盐酸头孢甲肟冻干粉针的制备方法 Download PDFInfo
- Publication number
- CN101721378B CN101721378B CN2009100640007A CN200910064000A CN101721378B CN 101721378 B CN101721378 B CN 101721378B CN 2009100640007 A CN2009100640007 A CN 2009100640007A CN 200910064000 A CN200910064000 A CN 200910064000A CN 101721378 B CN101721378 B CN 101721378B
- Authority
- CN
- China
- Prior art keywords
- abbott
- vacuum
- freeze
- dried powder
- powder injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- MPTNDTIREFCQLK-UNVJPQNDSA-N cefmenoxime hydrochloride Chemical compound [H+].[Cl-].S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C.S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C MPTNDTIREFCQLK-UNVJPQNDSA-N 0.000 title claims abstract description 66
- 239000000843 powder Substances 0.000 title claims abstract description 36
- 238000002347 injection Methods 0.000 title claims abstract description 29
- 239000007924 injection Substances 0.000 title claims abstract description 29
- 229960003791 cefmenoxime Drugs 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 18
- 239000004475 Arginine Substances 0.000 claims abstract description 16
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000007710 freezing Methods 0.000 claims abstract description 15
- 230000008014 freezing Effects 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 7
- 238000001291 vacuum drying Methods 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000008215 water for injection Substances 0.000 claims description 13
- 238000004108 freeze drying Methods 0.000 claims description 11
- 238000012856 packing Methods 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 claims description 4
- 230000005496 eutectics Effects 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 206010004142 Bartholinitis Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- JYXACOFERDBGGQ-RHSMWYFYSA-N cefathiamidine Chemical compound S1CC(COC(C)=O)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CSC(NC(C)C)=NC(C)C)[C@H]21 JYXACOFERDBGGQ-RHSMWYFYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
盐酸头孢甲肟用量g | 精氨酸用量g | 外观 |
40 | 0 | 皱缩 |
40 | 4 | 饱满、苏松、有大量空隙 |
40 | 10 | 饱满、苏松 |
40 | 20 | 饱满 |
40 | 40 | 饱满 |
制剂 | 本发明 | 专利03117380.2 | 专利200810163511.X |
无菌合格率% | 99.98 | 99.54 | 99.89 |
制剂 | 本发明 | 专利03117380.2 | 专利200810163511.X |
5ml注射用水 | 溶解迅速 | 时间稍长 | 溶解最慢 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100640007A CN101721378B (zh) | 2009-09-15 | 2009-09-15 | 盐酸头孢甲肟冻干粉针的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100640007A CN101721378B (zh) | 2009-09-15 | 2009-09-15 | 盐酸头孢甲肟冻干粉针的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101721378A CN101721378A (zh) | 2010-06-09 |
CN101721378B true CN101721378B (zh) | 2011-07-13 |
Family
ID=42443333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100640007A Expired - Fee Related CN101721378B (zh) | 2009-09-15 | 2009-09-15 | 盐酸头孢甲肟冻干粉针的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101721378B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813626B (zh) * | 2012-09-11 | 2014-03-05 | 天津市嵩锐医药科技有限公司 | 一种注射用无定型盐酸头孢甲肟化合物药物组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1526396A (zh) * | 2003-03-03 | 2004-09-08 | 中国医药集团总公司四川抗菌素工业研 | 一种可注射给药的盐酸头孢甲肟新剂型 |
CN1660116A (zh) * | 2004-12-24 | 2005-08-31 | 邢为藩 | 一种新的硫酸头孢匹罗组合物及其制备方法 |
CN101348494A (zh) * | 2008-09-02 | 2009-01-21 | 海南数尔药物研究有限公司 | 高纯度盐酸头孢甲肟及其制备方法 |
-
2009
- 2009-09-15 CN CN2009100640007A patent/CN101721378B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1526396A (zh) * | 2003-03-03 | 2004-09-08 | 中国医药集团总公司四川抗菌素工业研 | 一种可注射给药的盐酸头孢甲肟新剂型 |
CN1660116A (zh) * | 2004-12-24 | 2005-08-31 | 邢为藩 | 一种新的硫酸头孢匹罗组合物及其制备方法 |
CN101348494A (zh) * | 2008-09-02 | 2009-01-21 | 海南数尔药物研究有限公司 | 高纯度盐酸头孢甲肟及其制备方法 |
Non-Patent Citations (2)
Title |
---|
JP特开2004-161729A 2004.06.10 |
JP特开2007-238491A 2007.09.20 |
Also Published As
Publication number | Publication date |
---|---|
CN101721378A (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101627996B (zh) | 一种雷贝拉唑钠组合物及其制备方法 | |
CN100506213C (zh) | 一种注射用兰索拉唑冻干粉及其制备方法 | |
CN113005040B (zh) | 一种乳双歧杆菌冻干保护剂及其使用方法 | |
CN102228444B (zh) | 一种注射用n(2)-l-丙氨酰-l-谷氨酰胺制剂及其制备方法 | |
CN1994461A (zh) | 一种制备注射用还原型谷胱甘肽的冻干工艺 | |
CN100506215C (zh) | 一种头孢硫脒冻干粉针的制备方法 | |
CN101297809B (zh) | 头孢哌酮钠与舒巴坦钠混粉的制备方法 | |
CN101947208B (zh) | 一种供注射用的磷酸氟达拉滨组合物及其制备方法 | |
CN101721378B (zh) | 盐酸头孢甲肟冻干粉针的制备方法 | |
CN102367229B (zh) | 一种二乙酰氨乙酸乙二胺化合物及其药物组合物 | |
CN103585018A (zh) | 一种注射用还原型谷胱甘肽的新冻干方法 | |
CN102670524B (zh) | 一种注射用泮托拉唑钠冻干制剂及其制备方法 | |
CN105796509A (zh) | 一种倍他米松磷酸钠冻干粉针剂的制备方法 | |
CN101829065B (zh) | 注射用兰索拉唑组合物冻干粉 | |
CN103230373A (zh) | 一种注射用右兰索拉唑冻干粉及其制备方法 | |
CN103271884A (zh) | 一种兰索拉唑组合物及其制备方法 | |
CN104069074A (zh) | 一种注射用奥拉西坦及其制备方法 | |
CN104043103A (zh) | 一种多黏菌素e甲磺酸钠冻干制剂及其制备方法 | |
CN106913531B (zh) | 一种吗替麦考酚酯冻干组合物及其制备方法 | |
CN105434368A (zh) | 一种注射用还原型谷胱甘肽及其预冻方法 | |
CN100496489C (zh) | 一种富马酸尼唑苯酮冻干粉及其制备方法 | |
CN101926799A (zh) | 注射用奥美拉唑钠药物组合物及其制备方法 | |
CN111419804A (zh) | 一种注射用血管生成抑肽冻干制剂及其冻干方法 | |
CN103655490A (zh) | 盐酸伊达比星药物组合物及制备方法 | |
CN105726495B (zh) | 一种注射用短效苯并二氮杂卓盐药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN AOHE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WU QIUPING Effective date: 20140424 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510403 GUANGZHOU, GUANGDONG PROVINCE TO: 100022 CHAOYANG, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140424 Address after: 100022, B, block SOHO, 1204, Jianguo Road, 88, Beijing, Chaoyang District Patentee after: Hainan Union Pharmaceutical Co., Ltd. Address before: 510403, room 60, 201 North Road, Sanyuanli Avenue, Yuexiu District, Guangdong, Guangzhou Patentee before: Wu Qiuping |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110713 Termination date: 20140915 |
|
EXPY | Termination of patent right or utility model |